Adeno-associated virus: The gene therapy revolution faces manufacturing and safety hurdles Post author: Post published:April 5, 2024 Post category:uncategorized Recombinant adeno-associated virus (rAAV)-based genetic applications to treat human diseases. You Might Also Like Genetic link between PTSD and Alzheimer’s debunked in veterans study April 7, 2024 Neural implants face ethical hurdles, study finds April 7, 2024 Sweet news: Dark chocolate reduces type 2 diabetes risk December 10, 2024